Brooks Laboratories Ltd: No Pending Unpublished Price Sensitive Information, Share Price Movement Market-Driven

Brooks Laboratories Ltd has responded to a clarification sought regarding price movement. The company has disclosed all material information to the stock exchange, including information that could impact operations or performance, in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. There is no pending Unpublished Price Sensitive Information that could affect the price or volume behavior of the scrip. The company is not aware of the reason for the significant changes in its share price, attributing it to market-driven factors. The management is not connected with the changes in share prices. Brooks Laboratories Ltd reaffirms its commitment to adhere to compliances required under the Listing Regulations and other applicable laws.